UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,847 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Oil's sudden jump rattled macro markets and prompted crypto traders to rethink bitcoin price prediction: just as BTC ...
An ABA survey reveals strong public backing for guardrails on stablecoin yields linked to bank risk, underscoring reg...
As tensions rise, Iran warns of $200 barrels even as the U.S. and IEA launch a massive emergency oil release. The mov...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
In a Friday decision, the Tenth Circuit refused to hear Custodia Bank's final appeal, ending a five-year battle for d...
Inflation is pushing shoppers to hunt for value, and Target is answering with a broad price-cut program on 3,000 item...
A new study shows a troubling planning gap among executives with equity awards. Despite financial savvy, 44% lack a f...
Ripple tests a crucial $1.60 resistance, shaping this week’s ripple (xrp) price predictions as traders watch volume a...
Two data storage stocks just flashed golden crosses, signaling momentum as AI demand tightens capacity. Here’s what i...
Broadcom has unveiled the world’s first quantum-safe encryption embedded in silicon, a milestone that could reorder e...
A surge in wealth and demand for luxury goods in the Middle East is shadowed by Iran-related conflict risks, with Ber...